UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 2, 2023 4:30 P.M.
Form:
S-3
CIK:
0001836056
Company Name:
Ambrx Biopharma Inc.
File Number:
333-271008